Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • CRWD vs GSK✓SelectedUSD · GSKCRWD vs GSK performance historyLatest closeAs of-1.42%11/13
Stock and ETF performance explorer

CRWD vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+351.1%
GSK return
+65.8%
Excess return
+285.2%
Maximum drawdown
-44.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.4%+0.5%-1.9%-1.4%
7D+4.5%+1.1%+3.3%+4.6%
30D-9.1%+6.3%-15.4%-8.5%
3M+0.5%+1.8%-1.3%+0.7%
6M+61.1%+1.7%+59.5%+61.6%
YTD+93.4%+6.5%+86.8%+92.2%
1Y+71.1%+9.5%+61.6%+69.9%
3Y+351.1%+65.3%+285.8%+379.0%
All+351.1%+65.8%+285.2%+379.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling